| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2025 | TRACE-ABILITY INC | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44AG071409 | Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers. | 000 | 4 | NIH | 2/11/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $2,499,998 ) |
| | 2025 | 2025 | TRACE-ABILITY INC | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44AI162202 | Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based HIV imaging PET tracers on a single platform. | 000 | 3 | NIH | 3/10/2025 | $1,000,000 |
| | 2025 | 2025 | TRACE-ABILITY INC | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44AG071409 | Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers. | 001 | 4 | NIH | 4/29/2025 | $1,499,998 |
| | 2025 | 2022 | TRACE-ABILITY INC | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44AG071409 | Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers. | 000 | 2 | NIH | 2/11/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $2,517,311 ) |
| | 2024 | 2024 | TRACE-ABILITY INC | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | SB1CA192499 | Establishing industrial production of components that enable expanding accessibility of PET imaging to cancer patient population. | 000 | 5 | NIH | 5/2/2024 | $93,843 |
| | 2024 | 2024 | TRACE-ABILITY INC | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44AI162202 | Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based HIV imaging PET tracers on a single platform. | 000 | 2 | NIH | 1/12/2024 | $1,000,000 |
| | 2024 | 2024 | TRACE-ABILITY INC | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44AG071409 | Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers. | 002 | 3 | NIH | 8/7/2024 | $1,500,000 |
| | 2024 | 2023 | TRACE-ABILITY INC | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | U01FD006957 | Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry. | 000 | 4 | FDA | 8/19/2024 | $0 |
| | 2024 | 2022 | TRACE-ABILITY INC | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44AG071409 | Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers. | 001 | 2 | NIH | 7/30/2024 | $0 |
| | 2024 | 2022 | TRACE-ABILITY INC | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44AG071409 | Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers. | 000 | 2 | NIH | 1/31/2024 | $0 |
| | 2024 | 2021 | TRACE-ABILITY INC | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R43FD006914 | Rapid pre-release sterility test for PET Drugs. | 000 | 1 | FDA | 4/27/2024 | -$76,532 |
| | 2024 | 2020 | TRACE-ABILITY INC | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44MH119110 | Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients. | 000 | 3 | NIH | 3/4/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,156,157 ) |
| | 2023 | 2023 | TRACE-ABILITY INC | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | U01FD006957 | Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry. | 000 | 4 | FDA | 8/14/2023 | $1,000,000 |
| | 2023 | 2023 | TRACE-ABILITY INC | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | SB1CA192499 | Establishing industrial production of components that enable expanding accessibility of PET imaging to cancer patient population. | 000 | 4 | NIH | 4/20/2023 | $156,157 |
|
| Issue Date FY: 2022 ( Subtotal = $2,252,101 ) |
| | 2022 | 2022 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44AG071409 | Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers. | 001 | 2 | NIH | 3/31/2022 | $0 |
| | 2022 | 2022 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | U01FD006957 | Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry. | 000 | 3 | FDA | 8/1/2022 | $1,000,000 |
| | 2022 | 2022 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44AG071409 | Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers. | 000 | 2 | NIH | 1/12/2022 | $1,252,101 |
| | 2022 | 2021 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R43FD006914 | Rapid pre-release sterility test for PET Drugs. | 000 | 1 | FDA | 8/16/2022 | $0 |
| | 2022 | 2020 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44MH119110 | Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients. | 000 | 3 | NIH | 6/2/2022 | $0 |
| | 2022 | 2017 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | U01FD005517 | Mitigation of quality and compliance risks in radio-pharmaceutical production by implementation of an automated release testing technology. | 000 | 3 | FDA | 1/4/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $2,424,436 ) |
| | 2021 | 2021 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R43FD006914 | Rapid pre-release sterility test for PET Drugs. | 000 | 1 | FDA | 9/21/2021 | $168,087 |
| | 2021 | 2021 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | U01FD006957 | Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry. | 000 | 2 | FDA | 7/16/2021 | $1,000,000 |
| | 2021 | 2021 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44AG071409 | Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers. | 000 | 1 | NIH | 1/25/2021 | $1,256,349 |
| | 2021 | 2019 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R43CA235909 | Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based cancer imaging PET tracers on a single platform. | 000 | 1 | NIH | 3/15/2021 | $0 |
| | 2021 | 2018 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44CA192499 | Analytical Methods for Automated Quality Control of Cancer PET Imaging Tracer - [F-18]FDG | 000 | 3 | NIH | 4/5/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,810,568 ) |
| | 2020 | 2020 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | U01FD006957 | Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry. | 000 | 1 | FDA | 8/21/2020 | $999,998 |
| | 2020 | 2020 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44MH119110 | Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients. | 002 | 3 | NIH | 7/9/2020 | $810,570 |
| | 2020 | 2019 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44MH119110 | Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients. | 001 | 2 | NIH | 1/6/2020 | $0 |
| | 2020 | 2018 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44CA192499 | Analytical Methods for Automated Quality Control of Cancer PET Imaging Tracer - [F-18]FDG | 000 | 3 | NIH | 1/24/2020 | $0 |
| | 2020 | 2018 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44MH119110 | Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients. | 000 | 1 | NIH | 12/27/2019 | $0 |
| | 2020 | 2017 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | U01FD005517 | Mitigation of quality and compliance risks in radio-pharmaceutical production by implementation of an automated release testing technology. | 000 | 3 | FDA | 7/24/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $989,897 ) |
| | 2019 | 2019 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R43CA235909 | Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based cancer imaging PET tracers on a single platform. | 000 | 1 | NIH | 9/18/2019 | $299,987 |
| | 2019 | 2019 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | R44MH119110 | Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients. | 000 | 2 | NIH | 7/25/2019 | $689,910 |
| | 2019 | 2017 | TRACE-ABILITY, INC. | 6919B WOODLEY AVE | VAN NUYS | CA | 91406-4844 | LOS ANGELES | USA | U01FD005517 | Mitigation of quality and compliance risks in radio-pharmaceutical production by implementation of an automated release testing technology. | 000 | 3 | FDA | 8/15/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $1,431,175 ) |
| | 2018 | 2018 | TRACE-ABILITY, INC. | 6160 BRISTOL PKWY STE 200 | CULVER CITY | CA | 90230-6604 | LOS ANGELES | USA | R44MH119110 | Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients. | 001 | 1 | NIH | 8/13/2018 | $232,454 |
| | 2018 | 2018 | TRACE-ABILITY, INC. | 6160 BRISTOL PKWY STE 200 | CULVER CITY | CA | 90230-6604 | LOS ANGELES | USA | R44MH119110 | Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients. | 001 | 1 | NIH | 8/13/2018 | -$232,454 |
| | 2018 | 2018 | TRACE-ABILITY, INC. | 6160 BRISTOL PKWY STE 200 | CULVER CITY | CA | 90230-6604 | LOS ANGELES | USA | R44CA192499 | Analytical Methods for Automated Quality Control of Cancer PET Imaging Tracer - [F-18]FDG | 000 | 3 | NIH | 12/11/2017 | $1,198,721 |
| | 2018 | 2018 | TRACE-ABILITY, INC. | 6160 BRISTOL PKWY STE 200 | CULVER CITY | CA | 90230-6604 | LOS ANGELES | USA | R44MH119110 | Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients. | 000 | 1 | NIH | 8/8/2018 | $232,454 |
| | 2018 | 2017 | TRACE-ABILITY, INC. | 6160 BRISTOL PKWY STE 200 | CULVER CITY | CA | 90230-6604 | LOS ANGELES | USA | U01FD005517 | Mitigation of quality and compliance risks in radio-pharmaceutical production by implementation of an automated release testing technology. | 001 | 3 | FDA | 7/30/2018 | $0 |
| | 2018 | 2017 | TRACE-ABILITY, INC. | 6160 BRISTOL PKWY STE 200 | CULVER CITY | CA | 90230-6604 | LOS ANGELES | USA | U01FD005517 | Mitigation of quality and compliance risks in radio-pharmaceutical production by implementation of an automated release testing technology. | 000 | 3 | FDA | 12/8/2017 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $1,773,110 ) (Continued on the next page) |
|
